Naproxen Sodium

4 trials 1 recruiting MMusculoskeletal

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

4 Sponsors

11 Countries

Phase II

Phase IV

Phase II: 2 Phase IV: 2

Oversight events:

9 temporary halts 1 urgent safety measure across 2 trials

View oversight register →

Indications tested

Axial spondyloarthritis 1 Endometriosis 1

Sponsors using this IMP

Chugai Pharmaceutical Co. Ltd. 1 KRKA tovarna zdravil d.d. Novo mesto 1 Organon LLC 1 St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr 1

All trials

4 total

Direct comparison between NSAIDs and biosimilar TNFa blockers in patients with axial spondyloarthritis Recruiting

2024-513213-13-00 Phase IV 1 country St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr
A study to evaluate the efficacy and safety of AMY109 in women with endometriosis Ended

2023-507289-14-00 Phase II 3 countries Chugai Pharmaceutical Co. Ltd.
The effects of 2-week long treatment with naproxen sodium (Nalgesin® Forte) on synovial fluid cytokine and naproxen concentration and clinic… Ended

2023-505875-56-00 Phase IV 1 country KRKA tovarna zdravil d.d. Novo mesto
A study to investigate efficacy and safety of OG-6219 twice a day in 3 dose levels compared with Placebo in participants aged 18 to 49 with … Ended

2022-501310-57-00 Phase II 10 countries Organon LLC

Showing 1–4 of 4 trials

← All drugs A–Z